<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Duke_Design skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Duke/Design</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="mainContainer"><DIV id="menuContainer"><UL><LI><A href="https://2015.igem.org/Team:Duke">HOME</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Team">TEAM</A></LI><LI><A href="#">PROJECT
            					</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Description">Description</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Experiments">Experiments &amp; Protocols</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Results">Results</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Design">Design</A></LI></UL><LI><A href="#">PARTS
            					</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Parts">Team Parts</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Basic_Part">Basic Parts</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Notebook">NOTEBOOK</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Attributions">ATTRIBUTIONS</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Collaborations">COLLABORATIONS</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Practices">HUMAN PRACTICES</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Safety">SAFETY</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Modeling">MODELING</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Interlabstudy">INTERLAB STUDY</A></LI><LI><A href="https://2015.igem.org/Team:Duke/Software">SOFTWARE</A></LI></DIV><DIV id="contentContainer"><H2>Design</H2>



The following image is our intended final construct. It features dCas9, the antibiotic gRNAs, the lac promoter,  gRNA binding sites, and a programmable cell death gene. We aimed for completion; however, it was never fully realized in lab.

</DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>